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The standard functional tool for gait assessment in multiple sclerosis (MS) clinical trials has
been the 25-Foot Timed Walk Test, a measure of gait speed. Straight-line gait assessment
may not reflect adequately upon balance and coordination. Walking tests with turns may
add additional information towards understanding gait and balance status, and be more
reflective of ambulation in the community. Understanding the impact of turn parameters on
patient-reported outcomes of balance and walking would help MS clinicians better formulate
treatment plans for persons with gait limitations. In this study, ninety-one persons with MS
(Expanded Disability Status Score; EDSS, range: 0–6.5) were enrolled in an initial cross-
sectional study. Twenty-four subjects (EDSS, range:1.0–6.0) completed a follow-up visit an
average of 12 months later. Spatiotemporal gait analysis was collected at both visits using
APDM Opal wireless body-worn sensors while performing the Timed-Up-and-Go (TUG) and
6-Minute Walk Test (6MWT). For both cross-sectional and longitudinal data, regression
analyses determined the impact on the addition of turning parameters to stride velocity (SV),
in the prediction of self-reported balance confidence (Activities-Specific Balance Confidence
Scale (ABC)) and walking limitation (12-item Multiple Sclerosis Walking Scale (MSWS-12)).
The addition of 6MWT peak turn velocity (PTV) to 6MWT SV increased the predictive power
of the 6MWT for the ABC from 20% to 33%, and increased the predictive power from 28% to
41% for the MSWS-12. TUG PTV added to TUG SV also strengthened the relationship of
the TUG for the ABC from 19% to 28%, and 27% to 36% for the MSWS-12. For those with 1
year follow-up, percent change in turn number of steps (TNS%Δ) during the 6MWT added
to 6MWT SV%Δ improved the modeling of ABC%Δ from 24% to 33%. 6MWT PTV%Δ
added to 6MWT SV%Δ increased the predictive power of MSWS-12%Δ from 8% to 27%.
Conclusively, turn parameters improved modeling of self-perceived balance confidence and
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walking limitations when added to the commonly utilized measure of gait speed. Tests of
longer durations with multiple turns, as opposed to shorter durations with a single turn, mod-
eled longitudinal change more accurately. Turn speed and stability should be qualitatively
assessed during the clinic visit, and use of multi-faceted tests such as the TUG or 6MWT
may be required to fully understand gait deterioration in persons with MS.
Introduction
Gait impairments are well-documented in multiple sclerosis (MS). Persons with MS (PwMS)
have demonstrated decreased straight-line velocity and step length, lower limb swing asymme-
try, reduced maximum hip and knee extension, and an overall decrease in propulsive force
during walking [1]. The Timed 25-Foot Walk (T25FW), an objective measure of straight-line
gait speed, is considered one of the gold standard measures for research and clinical gait assess-
ment in PwMS [2]. While walking speed may reflect changes in lower extremity weakness and
spasticity, it may not reflect real world walking impairment. A recent study on the T25FW,
Timed-Up and Go (TUG), and Two-Minute Walking Test (2MWT) reported that gait vari-
ability in MS patients with a high rate of falls was captured least well by the T25FW [3]. Falls
were highly correlated to deteriorations in balance and coordination, and the TUG test, con-
sisting of turns and other postural transitions in addition to straight walking, was more
strongly associated with these changes [3]. Turns while ambulating may therefore be impor-
tant to evaluate balance and coordination.
We hypothesized that turn parameters would significantly strengthen the association
between clinical walking tests and self-reported measures of walking and balance, better than
the association from gait speed alone. The primary objective of this study was to evaluate this
hypothesis and become better informed about the value of clinical assessments which combine
straight walking and turns, Timed-Up and Go (TUG) and Six-Minute Walking Test (6MWT).
Methods
Participant recruitment
Approval for this study was given by the Washington University Human Research Protection
Office and Institutional Review Board. Written consent was obtained for each participant
prior to testing. This study, conducted at the John L. Trotter MS Center at Washington Uni-
versity School of Medicine, included baseline assessments in 91 PwMS, with longitudinal
assessments in 24 PwMS at a mean 12.2 months (range 9–17 months). The cross-sectional
study was conducted on the basis of convenience sampling over a period of six months in the
MS Center, and the longitudinal study occurred over a period of six months approximately
one year after the cross-sectional study. The 24 PwMS in the longitudinal study were enrolled
per convenience if they already had a physician appointment on the day of testing. Inclusion
criteria were age18 years, confirmed diagnosis by McDonald criteria, and Expanded Disabil-
ity Status Scale (EDSS) 0–6.5 [4]. Excluded were those with any other medical condition that
may affect ambulation: vision impairment, lower extremity orthopedic conditions limiting
ambulation, chronic pain, and morbid obesity.
Self-reported outcome measures
PwMS completed two self-report measures prior to an instrumented gait assessment, the
Activities-Specific Balance Confidence Questionnaire (ABC) and 12-Item Multiple Sclerosis
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Walking Scale Questionnaire (MSWS-12). The ABC quantifies self-perceived confidence in
balance on a scale from 0–100% through 16 questions [5]. The total score is reported from
0–100, with lower scores reflecting a lower balance confidence. The MSWS-12 quantifies self-
perceived walking limitations through 12 questions, with a total score range of 12–60 [6]. The
total score is transformed to a scale of 0–100, with higher scores reflecting a greater perceived
impact of MS on walking. The MSWS-12 measures self-reported difficulties in standing, walk-
ing and running capacity, and speed. The ABC scale focuses specifically upon balance and
unsteadiness in terms of reaching, postural transitions, and specific community scenarios (e.g.
icy sidewalks, escalators, ramps, cars). Both measures have been found to be valid and reliable
in characterizing their respective features [5,6].
MS clinical disability assessment
Disability in multiple sclerosis was measured using the Expanded Disability Status Scale
(EDSS) [7], a scale scored with half point steps from 0 through 10, with increasing scores
denoting greater magnitudes of disability.
Instrumented gait assessment
Spatiotemporal parameters of gait and turning were calculated during the T25FW, TUG, and
6MWT using APDM Opal wireless sensors and Mobility Lab software (APDM, Portland, OR,
USA) following manufacturers guidelines [8]. The reliability and validity of the Mobility Lab
System has been established in many studies [8–10]. The T25FW is a MS clinical test of walk-
ing 25 feet [2].
Participants underwent two trials of the T25FW. TUG is a gait and postural transition test:
standing up from a chair, walking 7 meters to a cone, turning around a cone, walking back to
the chair, and turning to sit down [11,12]. Patients were instructed by the following phrasing
“Please walk as fast as you can, but as safely as you can.” The average of 3 trials of TUG were
utilized. The 6MWT is a test of walking endurance and turning: walking 50 feet back and forth
around two cones for six minutes [13,14].
Data analytical approach
Step-wise regression analyses, which can determine additive properties of variables, were pri-
marily used to achieve the objective of the study and test the hypothesis. The baseline predic-
tive variable was one that was established in literature and could be readily obtained from
straight-line gait. The secondary predictive variables added to the baseline were turn parame-
ters that were simple to interpret and were deemed by MS clinicians in this project as having
potential to obtain using more cost-effective technology than the sensors in the future. The
variables were extracted at both the initial time point for the cross-sectional study and the fol-
low-up time point for use in the longitudinal study.
For the longitudinal analysis, further processing was done to obtain percent change
between the initial and follow-up time point values for each variable. Percent change specifi-
cally was chosen because of its consistent interpretation across variables.
Cross-sectional analysis
Stride Velocity (SV), defined as Mobility Lab’s measure of gait speed (meters/second from the
accelerometer in the sensors), was the baseline variable for modeling the relationship between
gait parameters and self-reported outcomes [15]. Average Peak Turn Velocity (PTV) (degrees/
second from the gyroscope in the sensors) for TUG and 6MWT were utilized as additional
Turns predict balance and walking deterioration in MS
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variables for the turn analysis. PTV is defined by Mobility Lab as the peak (95%) angular veloc-
ity of the trunk during turning [15]. Variables were generally normal in distribution, with min-
imal negative skews observed for 6MWT SV (Sk = -0.63) and TUG SV (Sk = -0.16) and slight
positive skews observed for 6MWT PTV (Sk = 0.39) and TUG PTV (Sk = 0.36).
Step-wise regression analyses were conducted using IBM SPSS 18.0 software to determine
the additive value of PTV to SV in the correlation of patient reported outcomes, ABC and
MSWS-12. The F-test of overall significance with a one-tailed alternative hypothesis was used
to determine statistically significant increases in predictive power.
Longitudinal analysis
Percent change from baseline (%Δ) was obtained for SV, PTV, and Turn Number of Steps
(TNS), defined as the number of the steps per turn, for the 24 patients who participated in the
longitudinal follow-up [15]. Variables were generally normal in distribution, with slight nega-
tive skews observed for the following: 6MWT SV (both time points; Ski = -0.63, Skf = -0.41),
6MWT TNS (follow-up; Sk = -0.59), TUG SV (both time points; Ski = -0.16, Skf = -0.36), and
TUG TNS (initial; Sk = -0.11). Slight positive skews were observed for: 6MWT PTV (both time
points; Ski = 0.39, Skf = 0.80), 6MWT TNS (initial; Sk = 0.45), TUG PTV (both time points; Ski
= 0.36, Skf = 0.32), and TUG TNS (follow-up; Sk = 0.08).
Outcomes for comparison included percent change from baseline in self-reported measures
(ABC%Δ, MSWS%Δ) and clinical disability change (ΔEDSS). Step-wise regression analyses
were conducted for the TUG and 6MWT to determine the value of adding PTV%Δ or TNS%
Δ, to SV%Δ, in the prediction of ABC%Δ and MSWS%Δ.
Results
Participant demographics
Demographics for the cross-sectional and longitudinal participants were notable for median
age 49, mild disability by EDSS (2.5), and disease duration of 9 years as seen in Table 1.
Cross-sectional results of turn parameters
To evaluate the extent to which the ABC and MSWS-12 were measuring similar constructs,
the relationship between participant responses was determined to have an R2 = 64% (ABC vs.
MSWS-12, r = -0.80, p< 0.0001), indicating that 36% of the variability of one scale remained
unaccounted when using the other scale. In comparing the overlap between straight and turn-
ing parameters, we noted that 62–72% of the information from a straight-line walking parame-
ter was unaccounted by a turning velocity walking parameter. Pearson correlation coefficients
for the predictive measures of 6MWT and TUG were moderate and positively correlated:
TUG SV vs. TUG PTV (r = 0.58, p< 0.0001), and between 6MWT SV vs. 6MWT PTV
(r = 0.53; p< 0.0001).
Correlations were significantly strengthened when PTV was added to SV in the prediction
of ABC. Baseline R2 value for ABC vs. TUG SV was 19% and increased to 28% when TUG
PTV was added to the stepwise regression model (p< 0.01). Similarly, baseline R2 value for
the prediction of ABC by 6MWT SV was 20% and increased to 33% when 6MWT PTV was
added to the regression model (p< 0.01).
Similar results were found for MSWS-12 as the outcome measure. Baseline R2 value for the
prediction of MSWS-12 by TUG SV was 27%, having increased to 36% with the addition of
TUG PTV (p< 0.01). MSWS-12 by 6MWT SV increased the R2 from 28% to 41% with the
addition of 6MWT PTV (p< 0.01).
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Longitudinal results of turn parameters
Minimal clinically importance difference (MCID) in MSWS-12 is defined as a change of 7
points [16]. Minimal detectable change (MDC) for ABC has been established as 13 points [17].
MCID in EDSS scores has been reported as a change in 1.0 if EDSS 0–5.5 and a change in 0.5 if
EDSS > 6.0 [18]. MCID in shorter distance walking velocity has been reported as 20% and
0.13 m/s [19,20].
About 1/3 of PwMS experienced a MDC balance confidence (17% improved, 17% wors-
ened, 66% no change; Fig 1A). The majority of PwMS perceived a MCID in walking limitation
Table 1. Cross-sectional and longitudinal subject demographics.
Cross-Sectional (n = 91)
Mean SDa Median Range/IQRc
Age 47 11 49 Rd: 2–69;
IQR: 41–58
EDSS 2.5 0.7 2.5 R: 0–6.5;
IQR: 2.0–3.5
Disease Duration (years) 11 8 9 R: 1–37;
IQR: 3–14
Gender 79 females, 12 males
MS Sub-typeb 87 RRMS, 3 PPMS, 1 SPMS
Ethnicity 80 White, 9 Black,
2 Asian
MSWS-12 Score 28.4 26.0 21.4 R: 0–76;
IQR: 63–95
ABC Score 76.6 20.7 81.9 R: 27–100;
IQR: 5–52
6MWT Distance Walked 1405 310 1427 R: 406–2458;
IQR: 1210–1611
7-m TUG Duration 17.3 4.8 16.5 R: 10.7–43.2;
IQR: 13.1–18.7
Longitudinal (n = 24)
Mean SD Median Range
Age 51 11 49 R: 29–70;
IQR: 44–58
EDSS 2.5 0.5 2.5 R: 1.0–6.0;
IQR: 2.0–3.5
Duration between Visits (months) 12.2 2.0 11.4 R: 9–17;
IQR: 12–14
Gender 21 females, 3 males
MS Sub-type 24 RRMS, 0 PPMS, 0 SPMS
Ethnicity 22 White, 2 Black,
0 Asian
Age (years), EDSS, disease duration (years), MSWS-12 score, ABC score, 6MWT distance walked (feet), 7-m TUG
duration (seconds), gender, ethnicity, and diagnosed MS sub-type statistics for the 91 patients in the cross-sectional
analysis. Age, EDSS, duration between visits, gender, ethnicity, and MS sub-type statistics for the 24 patients in the
longitudinal analysis.
aSD = standard deviation
bRRMS = relapsing-remitting multiple sclerosis, PPMS = primary-progressive multiple sclerosis, SPMS = secondary-
progressive multiple sclerosis
cIQR = interquartile range
dR = range
https://doi.org/10.1371/journal.pone.0198178.t001
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(29% improved, 25% worsened, 46% no change; Fig 1B). A quarter of PwMS had a MCID in
stride velocity by the 6MWT (Fig 1C), but 96% were unchanged by the TUG (Fig 1D). Most
PwMS were stable in clinical disability by the EDSS (75% no change, 8% improved, 17% wors-
ened; Fig 1E).
Two turning parameters obtained during the 6MWT improved the modeling for ABC%Δ
and MSWS%Δ, but not when obtained from the TUG. Baseline R2 value for MSWS%Δ by
6MWT SV%Δ was 8%, improving to 27% when 6MWT PTV%Δ was added (p< 0.05). Base-
line R2 value for ABC%Δ by 6MWT SV%Δ was 24%, improving to 33% with the addition of
TNS%Δ to the regression model (p< 0.05). No improvement in modeling was observed when
6MWT PTV%Δ was added to ABC%Δ, and when 6MWT TNS%Δ was added to MSWS%Δ.
Fig 1. Clinical status change of ABC, MSWS-12, stride velocity in 6MWT, stride velocity in TUG, and EDSS. Longitudinal clinical status
change in self-report balance confidence and walking limitation, stride velocity in a longer duration and shorter duration test, and clinical
disability in 24 MS subjects.
https://doi.org/10.1371/journal.pone.0198178.g001
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For the TUG, neither PTV%Δ nor TNS%Δ improved the models for ABC%Δ and MSWS%Δ
(all p> 0.05). However, the change in total percent change in TUG duration did predict R2 =
25% of the changes in MSWS-12 and R2 = 18% of the ABC.
Discussion
This study demonstrated that turns are an important predictor of patient-reported balance
confidence and walking limitation, as measuring turns improves the correlation between gait-
based outcome measures and patient report of walking and balance limitations. While stride
velocity parameters did correlate with the patient report of home and community ambulation,
the clinical relationship was enhanced with the turning component. Consistent results were
found in the cross-sectional analysis, whether using a test consisting of a single turn (TUG) or
multiple turns (6MWT). For the longitudinal analysis, multiple turns appeared to more accu-
rately capture the impairment for the 6MWT over the TUG. Although the longitudinal cohort
was smaller than the cross-sectional cohort, this preliminary result suggests that including sev-
eral turns could be a more sensitive way to better capture changes in balance confidence and
walking limitation.
Our results also emphasize that turn speed and stability are important to assess clinically.
While the sensors in the present study may not be widely available, the result may still be trans-
lated into clinical practice with the use of other cost-effective technologies, as determined by
future studies. Health care professionals who want to properly assess gait should utilize a clear
hallway at least 20 feet long, and ask the patient to make several turns under observation cou-
pled with data collection from these technologies. Having the PwMS walk in a small exam
room is not sufficient for proper assessment of gait that replicates day-to-day activity in the
community. Interim, as studies determine the technologies most appropriate for this purpose,
an experienced clinician may be able to qualitatively assess turning hesitation and number of
steps by eye, as part of the comprehensive evaluation.
While the role and practicality of gait sensors in routine clinical practice remains unknown,
gait sensors and quantitative measures of turning may have potential as an outcome measure
for clinical trials. Current clinical measures like stride velocity during a short-distance test do
not capture all components of ambulation such as fatigue, balance, and symmetry and hence
may correlate poorly with PROs [21]. This may be problematic as a clinician attempts to
understand how patients are feeling on a day-to-day basis in their community rather than an
artificial clinic setting. Evaluating new parameters like turns during clinical assessment can
help improve correlation to PROs, detect clinical changes in balance and coordination not cap-
tured by current tests, and ultimately aid a clinician in formulating the appropriate care plan.
An interesting finding from the longitudinal analysis was that different turn parameters
improved predictive power of different PROs. We believe changes in TNS better corresponded
to changes in ABC because wider turns with a greater number of steps from the initial testing
indicate a decrease in balance confidence and more caution upon changing direction. PTV%Δ
may have better predicted MSWS%Δ because decreased turn velocity suggests a decreased
ability to adjust gait and change direction. Because correlation of longitudinal changes in
balance confidence and walking limitation seemed to improve with a test of longer duration,
this may justify the inclusion of the 6MWT or 2MWT in future therapeutic trials and other
interventions.
Collectively, our results suggest that while T25FW does provide a quick and simple method
for functional gait metrics, its singular measure of stride velocity can be suboptimal for clinical
gait assessment in PwMS. Previous work has shown that the T25FW predicts only 18% of gait
variability in patients with a high fall risk, compared to 29% for the TUG [3]. We obtained a
Turns predict balance and walking deterioration in MS
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similar result by demonstrating that TUG duration outperformed the straight-line walking
component of gait (SV) at predicting longitudinal changes in walking limitation. Because the
TUG also has a turn component to contribute additional predictive power, there may be merit
in clinics shifting away from the T25FW to the TUG.
A number of previous studies have already suggested that MS clinics should begin using the
TUG during clinical gait assessment due to its holistic nature [3,22]. One study reported the
strong convergent validity the TUG has with other established measures of ambulation, such
as T25FW, 6MWT, MSWS-12, and EDSS [22]. Another study demonstrated the reliability and
utility of inertial sensors in quantifying the TUG [23]. With these two findings as a premise,
we were able to quantitate the rationale for the added value. It is notable, however, that over
50% of the variance of PROs remains unpredicted. It may be difficult to predict this variance
with tests in a closed clinic setting, as variables such as uneven lighting, incline, obstacles,
pedestrians, etc often present in a community setting cannot be replicated.
Several study limitations are worth noting. Our longitudinal analysis consisted of only 24
RRMS patients, and would benefit from a future study with a larger cohort representative of
the spectrum of MS. Longer follow-up and additional visits would also be recommended.
While the total TUG duration and 6MWT could be used in clinic at present, and TNS could be
documented in the record, newer and more affordable methods to assess turns may become
available as technology advances.
Future studies would include a larger cohort, a multi-year assessment, and further broaden
inclusion across the spectrum of MS subtypes and disabilities. We would like to better assess
the impact and sensitivity of longitudinal analyses for TUG, 2MWT, and 6MWT. With a larger
population, a stratified analysis based upon disability may show that certain tests perform opti-
mally for specific EDSS scores. Lastly, other technology such as a motion capture system, gait
mat, Fit-Bit, and smart phone app utilizing a smart phone’s in-built sensors should be com-
pared against the APDM Opal sensors during these tests [24,25]. Because many MS clinics
may be unable to afford the Opal APDM wireless sensors, finding a more accessible technology
than the sensors with comparable efficiency, validity, and reliability would be ideal.
Conclusions
Turns are an important predictor of patient-reported balance confidence and walking limita-
tion. Although clinical disability is indeed better represented by a longer duration walking test,
the TUG contains more information than the current gold-standard 25-Foot Walk Test and is
of similar testing duration, thus making it a practical alternative for clinics. Further work must
be done longitudinally on the TUG, 2MWT, and 6MWT, and more cost-effective technology
to quantify turns must be found. In the interim, obtaining TUG duration as an outcome vari-
able, and documenting TNS during gait assessment would be of the most value for MS clinics.
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